7-Nov-2019: The global spinal cord
stimulation devices market size is anticipated to
reach USD 3.58 billion by 2026 registering a CAGR of 8.7%, according to a new
report by Grand View Research, Inc. Increasing incidence of failed back
syndrome and complex regional pain syndrome is anticipated to boost the market
growth. Failed back syndrome occurs as a chronic pain after spinal surgeries
for back or leg pain. After spinal surgery, the pain gets reduced or the
condition may get worst due to scar tissue which build up around the spinal
nerve roots.
Spinal cord
stimulation device is used to treat patients who failed to get the result from
spinal surgeries, by blocking the pain before it reaches the brain. Thus,
increasing number of patients suffering from chronic pain after surgeries is
likely to augment the product demand over the forecast period. In addition,
technological advancements are expected to fuel the market growth further. For
instance, Medtronic’s Intellis is a smallest implantable spinal cord stimulator
designed to overcome limitations with the current systems.
The high dose
therapy of the device helps reduce the pain for the patients suffering from
diseases, such as degenerative disk disease. Key companies are introducing
technologically enhanced products to gain competitive advantage in the
industry. For instance, in January 2019, Boston Scientific launched its Spectra
WaveWriter spinal cord stimulator in Europe. It is used for the treatment of
chronic pain through electrical impulses. This new system also allows
physicians and patients to customize their therapy.
In
depth research report on Spinal Cord Stimulation Devices Market
Further key findings from the study suggest:
·
Rechargeable device segment led the global market in 2018 and
is projected to expand further at the fastest CAGR from 2018 to 2026
·
This is attributed to the factors, such as new product
launches by key companies and increasing number of patients suffering from
neuropathic pain
·
Failed back syndrome was the dominant application segment in
2018 owing to high number of patients suffering from pain after spinal
surgeries
·
North America led the global spinal cord stimulation devices
market in 2018 owing to the increased incidence of post-laminectomy syndrome
followed by chronic longstanding back pain
Grand View Research
has segmented the global spinal cord stimulation devices market on the basis of
product, application, and region:
Spinal Cord Stimulation Devices Product Outlook (Revenue, USD
Million, 2015 - 2026)
·
Rechargeable
·
Non-rechargeable
Spinal Cord Stimulation Devices Application Outlook (Revenue,
USD Million, 2015 - 2026)
·
Failed Back Syndrome
·
Complex Regional Pain Syndrome
·
Degenerative Disk Disease
·
Unsuccessful Disk Surgery
·
Others
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. is the
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment